Medindia

X

Roche Rolls Out Lung Cancer Drug In India

by Medindia Content Team on  April 12, 2006 at 6:17 PM Cancer News   - G J E 4
Roche Rolls Out Lung Cancer Drug In India
Indian Pharmaceutical Industry is richer with the availability of one more beneficial drug, used in the treatment of lung cancer. Tarceva, the name by which the drug is known is produced by the Swiss-pharma company Roche, and will now be available in India
Advertisement

This is certainly a fresh lease of life to nearly 1, 60, 000 lung cancer patients in India. Tarceva has been available in the US since 2004 and in the European Union since 2005. This drug is normally administered to patients with advanced lung cancer, who have not responded well to even one chemotherapy treatment.

Advertisement
Tarceva is an established effective treatment for lung cancer, and perhaps the only epidermal growth factor receptor-inhibitor, to offer high survival rates in the treatment of lung cancer
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All